Clinical Trial Update: Pilot Clinical Trial of Repeated Doses of Macimorelin to Assess Safety and Efficacy in Patients With Cancer Cachexia [Phase 2]

View source ↗

Summary

Phase 2 pilot trial assessing repeated doses of macimorelin for safety and efficacy in cancer cachexia has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer Cachexia

Drugs mentioned

• Macimorelin (macimorelin)

Snippet

Sponsor: Garcia, Jose M., MD, PhD | Conditions: Cancer Cachexia | Phase 2 | Status: COMPLETED | Results posted: 2024-03-19